Sirona Biochem Corp.
SRBCF
Rank in Stocks
#32636
Sirona Biochem Corp. operates as a biotechnology company dedicated to... Sirona Biochem Corp. operates as a biotechnology company dedicated to uncovering and commercializing active ingredients for both cosmetic and pharmaceutical uses, with a commercial presence in Canada and France. Key initiatives include the development of a cosmetic skin brightener and a pharmaceutical solution for diabetes. Beyond these, the company is engaged in several other projects, such as building a library of anti-aging and cell-protective compounds, creating a novel anti-wrinkle agent, and pursuing an antiviral research program. A notable collaboration exists with the International Centre for Genetic Engineering and Biotechnology (ICGEB) for the joint development of an antiviral compound library. Established in 2006, the business, originally named High Rider Capital Inc., rebranded as Sirona Biochem Corp. in May 2009 and maintains its headquarters in Vancouver, Canada.
Share Price
$0.0051
Last synced: 2026-11-09
Market Cap
$1.32M
Change (1 day)
0.00%
Change (1 year)
5,000.00%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Sirona Biochem Corp. (SRBCF)
Category
Healthcare
EPS for Sirona Biochem Corp. (SRBCF)
EPS as of July 2024 TTM: $-0.01
According to Sirona Biochem Corp.'s latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2023 the company had an EPS of $-0.01, equal to its 2022 EPS of $-0.01.
EPS history for Sirona Biochem Corp. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.01 | -25.00% |
| 2023 | $-0.01 | -33.03% |
| 2022 | $-0.01 | 32.93% |
| 2021 | $-0.01 | -40.15% |
| 2020 | $-0.01 | -20.35% |
| 2019 | $-0.02 | 207.14% |
| 2018 | $-0.01 | -74.19% |
| 2017 | $-0.02 | 56.12% |
| 2016 | $-0.01 | -29.08% |
| 2015 | $-0.02 | -26.32% |
| 2014 | $-0.03 | -7.96% |
| 2013 | $-0.03 | -28.29% |
| 2012 | $-0.04 | -13.33% |
| 2011 | $-0.05 | 17.13% |
| 2010 | $-0.04 | -22.76% |
| 2009 | $-0.05 | 403.92% |
| 2008 | $-0.01 | -87.70% |
| 2007 | $-0.08 | 0.00% |
| 2006 | 0.00 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | -208,900.00% |
US
|
|
| $-7.07 | 94,166.67% |
US
|
|
| $-5.29 | 70,433.33% |
AU
|
|
| $12.88 | -171,834.67% |
BE
|
|
| $21.56 | -287,566.67% |
NL
|
Questions about Sirona Biochem Corp.'s earnings per share (EPS)
What is Sirona Biochem Corp.'s earnings per share (EPS)?
Sirona Biochem Corp.'s earnings per share (EPS) over the last twelve months is $-0.01, as of Jul 2024.
What was Sirona Biochem Corp.'s earnings per share (EPS) in 2023?
In 2023, Sirona Biochem Corp.'s earnings per share (EPS) was $-0.01, compared with $-0.01 in 2022.
How has Sirona Biochem Corp.'s earnings per share (EPS) changed since 2018?
From 2018 to 2023, Sirona Biochem Corp.'s earnings per share (EPS) was highest in 2023 ($-0.01) and lowest in 2019 ($-0.02).
How does Sirona Biochem Corp.'s earnings per share (EPS) compare with similar companies?
Sirona Biochem Corp.'s earnings per share (EPS) ($-0.01) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.